Skip to main content
Clinical Trials/NCT07506044
NCT07506044RecruitingNot Applicable

The Effect of Different Doses of Dexmedetomidine as an Adjuvant to Bupivacaine for Parturients Having Dural Puncture Epidural Technique to Elaborate Labor Pain

Menoufia University2 sites in 1 country140 target enrollmentStarted: May 30, 2026Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
140
Locations
2

Study Overview

Brief Summary

The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for epidural labor analgesia, and to assess the benefits of the dural puncture epidural.

Detailed Description

The primary efficacy point is the total dose of bupivacaine administered during labor. The secondary endpoints include the VAS pain scores, number of administered additional doses, incidence of motor block, delivery type (spontaneous vaginal or cesarean), maternal satisfaction, and complications such as hypotension, fetal bradycardia, and epidural-related maternal fever.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Women who attend the Emergency Department in labor, with cervical dilation of 3-5 cm,
  • normally presented singleton fetus, intact fetal membranes, and who are free of

Exclusion Criteria

  • Exclusion Criteria:
  • Abnormal fetal presentation or lie, 'premature rupture of membranes, maternal fever, fetal distress, pregnancy-induced diseases
  • abnormal placental position,
  • ASA grade>II
  • marked obesity,
  • allergy or contraindications to the used drugs,
  • spinal deformity or disorders 'cutaneous diseases or infection at the injection site

Arms & Interventions

Epidural puncture with dexmedetomidine 0.4 (Bup/DEX0.6 )

Active Comparator

Combined epidural with epidural puncture using bupivacaine plus dexmetomedine0.4

Intervention: Dexmedetomidine 0.4 added (Drug)

Epidural puncture with dexmedetomidine 0.6 (Bup/DEX0.6 )

Active Comparator

Combined epidural with epidural puncture using bupivacaine plus dexmetomedine0.6

Intervention: Epidural Catheter with bupivacaine (Device)

Epidural puncture with dexmedetomidine 0.6 (Bup/DEX0.6 )

Active Comparator

Combined epidural with epidural puncture using bupivacaine plus dexmetomedine0.6

Intervention: Epidural with dural puncture (Device)

Epidural puncture with dexmedetomidine 0.6 (Bup/DEX0.6 )

Active Comparator

Combined epidural with epidural puncture using bupivacaine plus dexmetomedine0.6

Intervention: Dexmedetomidine 0.6 added (Drug)

Epidural group with bupivacaine CE

Active Comparator

Epidural with plain bupivacaine DPE

Intervention: Epidural Catheter with bupivacaine (Device)

Epidural puncture with bupivacaine

Active Comparator

Combined epidural with epidural puncture using bupivacaine

Intervention: Epidural Catheter with bupivacaine (Device)

Epidural puncture with bupivacaine

Active Comparator

Combined epidural with epidural puncture using bupivacaine

Intervention: Epidural with dural puncture (Device)

Epidural puncture with dexmedetomidine 0.4 (Bup/DEX0.6 )

Active Comparator

Combined epidural with epidural puncture using bupivacaine plus dexmetomedine0.4

Intervention: Epidural Catheter with bupivacaine (Device)

Epidural puncture with dexmedetomidine 0.4 (Bup/DEX0.6 )

Active Comparator

Combined epidural with epidural puncture using bupivacaine plus dexmetomedine0.4

Intervention: Epidural with dural puncture (Device)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

rabab Mohammad habeeb

Principle investigator

Menoufia University

Study Sites (2)

Loading locations...

Similar Trials